IE
AGRX

Israel Englander’s Agile Therapeutics AGRX Stock Holding History

Israel Englander’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-911
Closed -$10K – 7120
2023
Q1 		$10K Sell
911
-245
-21% -$3.14K ﹤0.01% 6034
2022
Q4 		$13K Sell
1,156
-2,581
-69% -$30K ﹤0.01% 6152
2022
Q3 		$55K Buy
3,737
+3,398
+1,002% +$83.6K ﹤0.01% 6158
2022
Q2 		$20K Sell
339
-82
-19% -$11.9K ﹤0.01% 6489
2022
Q1 		$176K Sell
421
-48
-10% -$30.6K ﹤0.01% 5882
2021
Q4 		$458K Sell
469
-1
-0.2% -$1.41K ﹤0.01% 5131
2021
Q3 		$903K Sell
470
-282
-38% -$638K ﹤0.01% 4802
2021
Q2 		$2M Buy
+752
New +$2.48M ﹤0.01% 3967
2020
Q3 		– Sell
-312
Closed -$1.74M – 4947
2020
Q2 		$1.74M Sell
312
-382
-55% -$1.98M ﹤0.01% 2633
2020
Q1 		$2.58M Buy
694
+641
+1,209% +$3.68M 0.01% 1825
2019
Q4 		$266K Sell
53
-21
-28% -$73.3K ﹤0.01% 3724
2019
Q3 		$175K Buy
+74
New +$182K ﹤0.01% 3826
2018
Q1 		– Sell
-21
Closed -$112K – 4204
2017
Q4 		$112K Sell
21
-51
-71% -$475K ﹤0.01% 3644
2017
Q3 		$639K Buy
72
+7
+11% +$53.8K ﹤0.01% 2730
2017
Q2 		$488K Buy
+65
New +$450K ﹤0.01% 2815
2015
Q2 		– Sell
-10
Closed -$193K – 3979
2015
Q1 		$193K Buy
+10
New +$175K ﹤0.01% 3314
2014
Q3 		– Sell
-56
Closed -$975K – 4088
2014
Q2 		$975K Buy
+56
New +$810K ﹤0.01% 2217

Other funds holding AGRX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Israel Englander's AGRX Position: Q2 2023 in Review

Israel Englander sold out of Agile Therapeutics (AGRX) in Q2 2023, closing a stake of 911 shares — an estimated $10K sold.

Israel Englander first reported a position in AGRX in Q2 2014 and held it in 17 quarters. The position peaked at $2.58M in Q1 2020. 16 funds tracked by Wall St. Rank hold AGRX as of Q2 2023.

  • Israel Englander reported no remaining Agile Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Israel Englander sold 911 Agile Therapeutics shares in Q2 2023, an estimated $10K.
  • Israel Englander first reported a position in Agile Therapeutics in Q2 2014 and held it in 17 quarters.
  • Israel Englander's Agile Therapeutics position peaked at $2.58M in Q1 2020.
  • 16 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.